Staff Profile

Steve is a Senior Lecturer within the Health Economics Group within the Population Health Services Institute. His research interests relate to economic evaluation and evidence synthesis, including both decision-analytical modelling, all forms of meta-analysis, and econometric techniques. He has conducted research in a variety of areas, including alcohol reduction, reduction of hospital acquired infections, oral nutrition, diagnostic tests (home use, point of care, laboratory, sepsis, diabetic retinopathy, COPD exacerbations), behaviour change (attending diabetic retinopathy screening, change in Antimicrobial Stewardship), dementia care pathways, primary biliary cholangitis, drugs for early and advanced cancers, diagnostic and surgical techniques for bladder and bile duct cancers, hyperhidrosis, NSAIDS after major surgery, breastfeeding, osteoporosis, acupuncture, ankylosing spondylitis and deep vein thrombosis.

Steve is the Director of the Newcastle TAR Group delivering technology appraisals for the National Institute of Health and Care Excellence.

• Articles

  • Yu G, Rice S, Heer R, Lewis R, Vadiveloo T, Mariappan P, Penegar S, Clark E, Tandogdu Z, Hall E, Vale L. Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial. European Urology Open Science 2023, 53, 67-77.
  • Coughlan D, Arisa O, Thomson K, Yu G, Pearson F, Kernohan A, Garcia Gonzalez-Moral S, Wallace S, Rice S. Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective. PharmacoEconomics 2023, Epub ahead of print.
  • Orozco Leal G, Johnson EE, Hosseinijebeli S, Robinson T, Homer T, Eastaugh C, Richmond C, Tanner L, Meader N, Kenny R, Wallace SA, Rice S. Considerations for the cure assumption in a NICE Single Technology Appraisal of nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small cell lung cancer: Evidence Assessment Group perspective. PharmacoEconomics 2023, 42, 133-136.
  • Beyer F, Rice S, Orozco-Leal G, Still M, O'Keefe H, O'Connor N, Stoniute A, Craig D, Pereira S, Carr L, Leeds J. Clinical and cost effectiveness of endoscopic bipolar radiofrequency ablation for the treatment of malignant biliary obstruction: a systematic review. Health Technology Assessment 2023, 27(7), 1-118.
  • Thomson K, Rice S, Arisa O, Johnson E, Tanner L, Marshall C, Sotire T, Richmond C, O'Keefe H, Mohammed W, Gosney M, Raffle A, Hanratty B, McEvoy CT, Craig D, Ramsay SE. Oral nutritional interventions in frail older people who are malnourished or at risk of malnutrition: a systematic review. Health Technology Assessment 2022, 26(51).
  • Thomson KH, Rice S, Arisa O, Johnson E, Tanner L, Marshall C, Sotire T, Richmond C, O'Keefe H, Mohammed W, Raffle A, Hanratty B, McEvoy CT, Craig D, Ramsay SE. Effectiveness and cost-effectiveness of oral nutritional supplements in frail older people who are malnourished or at risk of malnutrition: a systematic review and meta-analysis. The Lancet Healthy Longevity 2022, 3(10), E654-E666.
  • Coughlan D, McMeekin P, Flynn D, Ford GA, Lumley H, Burgess D, Balami J, Mawson A, Craig D, Rice S, White P. Secondary transfer of emergency stroke patients eligible for mechanical thrombectomy by air in rural England: economic evaluation and considerations. Emergency Medicine Journal 2021, 38(1), 33-39.
  • Rice S, Albani V, Minos D, Fattakhova G, Mells GF, Carbone M, Flack S, Varvaropoulou N, Badrock J, Spicer A, Sandford RN, Shirley MDF, Coughlan D, Hirschfield G, Taylor-Robinson SD, Vale L, Jones DEJ. Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom. Clinical Gastroenterology and Hepatology 2021, 19(4), 768-776.e10.
  • Balami JS, Coughlan D, White PM, McMeekin P, Flynn D, Roffe C, Natarajan I, Chembala J, Nayak S, Wiggam I, Flynn P, Simister R, Sammaraiee Y, Sims D, Nader K, Dixit A, Craig D, Lumley H, Rice S, Burgess D, Foddy L, Hopkins E, Hudson B, Jones R, James MA, Buchan AM, Ford GA, Gray AM. The cost of providing mechanical thrombectomy in the UK NHS: a micro-costing study. Clinical Medicine Journal 2020, 20(3), e40-e45.
  • Jones WS, Rice S, Power HM, Maniatopoulos G, Suklan J, Beyer F, Wilcox MH, Permain M, Simpson AJ, Price DA, Allen AJ. Cost consequences for the NHS of using a two-step testing method for the detection of Clostridium difficile with a point of care, polymerase chain reaction test as the first step. Diagnostics 2020, 10(10), 819.
  • Wong LL, Fisher HF, Stocken DD, Rice S, Khanna A, Heneghan MA, Oo YH, Mells G, Kendrick S, Dyson JK, Jones DEJ. The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility. Hepatology 2018, 68(4), 1487-1497.
  • Heslehurst N, Rankin J, McParlin C, Sniehotta FF, Howel D, Rice S, McColl E. GestationaL Obesity Weight management: Implementation of National Guidelines (GLOWING): A pilot cluster randomised controlled trial of a guideline implementation intervention for the management of maternal obesity by midwives. Pilot and Feasibility Studies 2018, (4), 47.
  • Carroll C, Kaltenthaler E, Hill-McManus D, Scope A, Holmes M, Rice S, Rose M, Tappenden P, Woolacott N. The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal Process. Value in Health 2017, 20(6), 785-791.
  • Kaltenthaler E, Carroll C, Hill-McManus D, Scope A, Holmes M, Rice S, Rose M, Tappenden P, Woolacott N. Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process. PharmacoEconomics Open 2017, 1(2), 99-108.
  • Kaltenthaler E, Carroll C, Hill-McManus D, Scope A, Holmes M, Rice S, Rose M, Tappenden P, Woolacott N. The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis. Health Technology Assessment 2016, 20(26), 1-74.
  • Lawrenson JG, Graham-Rowe E, Lorencatto F, Presseau J, Burr J, Ivers N, Quartilho A, Bunce C, Francis JJ, Grimshaw JM, Peto T, Rice S, Vale L. Interventions to increase attendance for diabetic retinopathy screening. Cochrane Database of Systematic Reviews 2016, 2016(1).
  • Graham-Rowe E, Lorencatto F, Lawrenson JG, Burr J, Grimshaw JM, Ivers NM, Peto T, Bunce C, Francis JJ, Vale L, Presseau J, Quartilho A, Rice S. Barriers and enablers to diabetic retinopathy screening attendance: Protocol for a systematic review. Systematic Reviews 2016, 5(1), 134.

• Conference Proceedings (inc. Abstracts)

  • Beyer F, Rice S, Orozco-Leal G, Still M, O'Keefe H, O'Connor N, Stoniute A, Craig D, Pereira S, Carr L, Leeds J. PTU-35 Endoscopic bipolar radiofrequency ablation for treating malignant biliary obstruction: Systematic review and meta-analysis. In: British Society of Gastroenterology (BSG) Annual Meeting. 2021, Online: BMJ Publishing Group.
  • Beyer F, Rice S, Orozco-Leal G, Still M, O'Keefe H, O'Connor N, Stoniute A, Craig D, Pereira S, Carr L, Leeds J. P-P21 Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by unresectable cancer: systematic review of clinical and cost effectiveness. In: UGI Congress 2021. 2021, Belfast: Oxford University Press.
  • Lumley H, Flynn D, Coughlan D, McMeekin P, Ford GA, Craig D, Rice S, Burgess D, Balami J, Mawson A, White P. Secondary transfers by helicopter emergency services for thrombectomy in rural England: a feasibility study (updated). In: UK Stroke Forum. 2019, Telford: Sage Publications Ltd.
  • Lumley H, Flynn D, Coughlan D, McMeekin P, Ford GA, Craig D, Rice S, Burgess D, Balami JS, Mawson A, White PM. Secondary Transfers by Helicopter Emergency Services for Thrombectomy in Rural England: a Feasibility Study. In: UK Stroke Forum 2018. 2018, Telford, UK: Sage Publications Ltd.
  • Flynn D, Coughlan D, McMeekin P, Ford GA, Craig D, Rice S, Burgess D, Balami J, Mawson A, Lumley H, White P. Secondary Transfer of Stroke Patients for Thrombectomy by Air Ambulance in England: A Cost-Effectiveness Analysis. In: European Stroke Organisation Conference. 2018, Gothenburg, Sweden: Sage Publications Ltd.
  • Balami JS, Coughlan D, McMeekin P, White PM, Flynn D, Roffe C, Wiggam I, Flynn P, Chembala J, Natarajan I, Dixit A, Hunter A, Foddy L, Hopkins E, Lumley H, Rice S, Burgess D, Craig D, Buchan AM, Ford GA, Gray A. Case Costing of Mechanical Thrombectomy for Acute Ischaemic Stroke in Routine Clinical Setting: Cost Differences Between Mothership vs Drip and Ship. In: UK Stroke Forum 2018. 2018, Telford, United Kingdom: International Journal of Stroke.
  • Rice SJ, Albani VJ, Fattakhova GE, Mells GF, Sandford R, Shirley M, Rushton SP, Coughlan D, Hirschfield GM, Taylor-Robinson S, Vale L, Jones D. Cost and utility estimates for patients at different stages in the natural history of Primary Biliary Cirrhosis (PBC) from the UK-PBC Cohort. In: 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016. 2016, Washington DC: Wiley-Blackwell.

• Reports

  • Robinson L, Poole M, McLellan E, Lee R, Amador S, Bhattarai N, Bryant A, Coe D, Corbett A, Exley C, Goodman C, Gotts Z, Harrison-Dening K, Hill S, Howel D, Hrisos S, Hughes J, Kernohan A, Macdonald A, Mason H, Massey C, Neves S, Paes P, Rennie K, Rice S, Robinson T, Sampson E, Tucker S, Tzelis D, Vale L, Bamford C. Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT. National Institute for Health Research, 2020. 8.
  • Wade R, Rice S, Llewellyn A, Moloney E, Jones-Diette J, Stoniute J, Wright K, Layton A, Levell N, Stansby G, Craig D, Woolacott N. Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis. 2017. Health Technology Assessment Volume: 21, Issue:80.

• Reviews

  • Beyer FR, Kenny RPW, Johnson E, Caldwell DM, Garnett C, Rice S, Simpson J, Angus C, Craig D, Hickman M, Michie S, Kaner EFS. Practitioner and digitally delivered interventions for reducing hazardous and harmful alcohol consumption in people not seeking alcohol treatment: a systematic review and network meta-analysis. Addiction 2023, 118(1), 17-29.
  • Rice S, Carr K, Sobiesuo P, Shabaninejad H, Orozco-Leal G, Kontogiannis V, Marshall C, Pearson F, Moradi N, O'Connor N, Stoniute A, Richmond C, Craig D, Allegranzi B, Cassini A. Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic review. The Lancet Infectious Diseases 2023, 23(7), e228-e239.
  • Lawrenson JG, Graham-Rowe E, Lorencatto F, Burr J, Bunce C, Francis JJ, Aluko P, Rice S, Vale L, Peto T, Presseau J, Ivers N, Grimshaw JM. Interventions to increase attendance for diabetic retinopathy screening. Cochrane Database of Systematic Reviews 2018, 2018(1), 1-231.